Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker KNSA
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Mark Ragosa Officer | KNSA Kiniksa Pharmaceuticals International, plc | 36,783 | $3.4M | 10b5-1 | Nov 2, 2026 | Form 4 ↗ 1 day later · 36,783 shares | Form 144 ↗ |
| Oct 30, 2026 | Sanj K. Patel Officer, Director | KNSA Kiniksa Pharmaceuticals International, plc | 553,794 | $51.6M | 10b5-1 | Oct 30, 2026 | Form 4 ↗ 4 days later · 402,494 shares | Form 144 ↗ |
| Oct 30, 2026 | Moat Ross Officer | KNSA Kiniksa Pharmaceuticals International, plc | 103,585 | $9.8M | 10b5-1 | Oct 30, 2026 | Form 4 ↗ 4 days later · 103,585 shares | Form 144 ↗ |
| Oct 30, 2026 | Michael R. Megna Officer | KNSA Kiniksa Pharmaceuticals International, plc | 47,540 | $4.6M | 10b5-1 | Oct 30, 2026 | Form 4 ↗ 4 days later · 36,260 shares | Form 144 ↗ |
| Oct 30, 2026 | John F. Paolini Officer | KNSA Kiniksa Pharmaceuticals International, plc | 96,000 | $8.9M | 10b5-1 | Oct 30, 2026 | Form 4 ↗ 4 days later · 96,000 shares | Form 144 ↗ |
| Sep 3, 2026 | Michael R. Megna Officer | KNSA Kiniksa Pharmaceuticals International, plc | 4,600 | $369.4K | 10b5-1 | Sep 3, 2026 | Form 4 ↗ same day · 4,600 shares | Form 144 ↗ |
| Jul 29, 2026 | Tessari Eben Former Affiliate | KNSA Kiniksa Pharmaceuticals International, plc | 67,062 | $5.3M | — | Jul 29, 2026 | — | Form 144 ↗ |
| Jul 29, 2026 | Cole G Bradley Director | KNSA Kiniksa Pharmaceuticals International, plc | 3,673 | $299.1K | — | Jul 29, 2026 | Form 4 ↗ 2 days later · 3,673 shares | Form 144 ↗ |
| May 1, 2026 | John F. Paolini Officer | KNSA Kiniksa Pharmaceuticals International, plc | 58,424 | $3.1M | 10b5-1 | May 1, 2026 | Form 4 ↗ 4 days later · 58,424 shares | Form 144 ↗ |
| Apr 28, 2026 | Sanj K. Patel Officer, Director | KNSA Kiniksa Pharmaceuticals International, plc | 344,591 | $17.8M | 10b5-1 | Apr 28, 2026 | Form 4 ↗ 2 days later · 508,339 shares | Form 144 ↗ |
| Apr 9, 2026 | Moat Ross Officer | KNSA Kiniksa Pharmaceuticals International, plc | 1,703 | $79.5K | 10b5-1 | Apr 9, 2026 | Form 4 ↗ 4 days later · 1,703 shares | Form 144 ↗ |
| Apr 9, 2026 | Michael R. Megna Officer | KNSA Kiniksa Pharmaceuticals International, plc | 6,625 | $309.3K | 10b5-1 | Apr 9, 2026 | Form 4 ↗ 4 days later · 6,625 shares | Form 144 ↗ |
| Apr 6, 2026 | Barry D. Quart Director | KNSA Kiniksa Pharmaceuticals International, plc | 20,000 | $1.0M | 10b5-1 | Apr 6, 2026 | Form 4 ↗ 2 days later · 6,901 shares | Form 144 ↗ |
| Apr 6, 2026 | Sanj K. Patel Officer, Director | KNSA Kiniksa Pharmaceuticals International, plc | 219,591 | $11.0M | 10b5-1 | Apr 6, 2026 | Form 4 ↗ 2 days later · 7,278 shares | Form 144 ↗ |
| Apr 6, 2026 | Moat Ross Officer | KNSA Kiniksa Pharmaceuticals International, plc | 2,367 | $115.0K | 10b5-1 | Apr 6, 2026 | Form 4 ↗ 2 days later · 2,367 shares | Form 144 ↗ |
| Mar 9, 2026 | Mark Ragosa Officer | KNSA Kiniksa Pharmaceuticals International, plc | 36,722 | $1.7M | 10b5-1 | Mar 9, 2026 | Form 4 ↗ 2 days later · 36,722 shares | Form 144 ↗ |
| Mar 2, 2026 | John F. Paolini Officer | KNSA Kiniksa Pharmaceuticals International, plc | 40,000 | $1.8M | 10b5-1 | Mar 2, 2026 | Form 4 ↗ 2 days later · 40,000 shares | Form 144 ↗ |
| Dec 15, 2025 | Barry D. Quart Director | KNSA Kiniksa Pharmaceuticals International, plc | 58,889 | $2.4M | 10b5-1 | Dec 15, 2025 | Form 4 ↗ 2 days later · 20,129 shares | Form 144 ↗ |
| Dec 8, 2025 | Mark Ragosa Officer | KNSA Kiniksa Pharmaceuticals International, plc | 72,686 | $3.0M | 10b5-1 | Dec 8, 2025 | Form 4 ↗ 2 days later · 42,841 shares | Form 144 ↗ |
| Nov 26, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 48,384 | $2.1M | 10b5-1 | Nov 26, 2025 | Form 4 ↗ 5 days later · 200 shares | Form 144 ↗ |
| Nov 17, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 12,470 | $514.2K | 10b5-1 | Nov 17, 2025 | Form 4 ↗ 2 days later · 12,470 shares | Form 144 ↗ |
| Oct 31, 2025 | John F. Paolini Officer | KNSA Kiniksa Pharmaceuticals International, plc | 82,542 | $3.1M | 10b5-1 | Oct 31, 2025 | Form 4 ↗ 4 days later · 82,542 shares | Form 144 ↗ |
| Oct 28, 2025 | Mark Ragosa Officer | KNSA Kiniksa Pharmaceuticals International, plc | 20,000 | $820.0K | 10b5-1 | Oct 28, 2025 | Form 4 ↗ 2 days later · 100 shares | Form 144 ↗ |
| Oct 28, 2025 | Mark Ragosa Officer | KNSA Kiniksa Pharmaceuticals International, plc | 20,000 | $820.0K | 10b5-1 | Oct 28, 2025 | Form 4 ↗ 2 days later · 100 shares | Form 144 ↗ |
| Oct 20, 2025 | Sanj K. Patel Officer, Director | KNSA Kiniksa Pharmaceuticals International, plc | 257,969 | $10.0M | 10b5-1 | Oct 20, 2025 | Form 4 ↗ 2 days later · 257,969 shares | Form 144 ↗ |
| Oct 20, 2025 | Michael R. Megna Officer | KNSA Kiniksa Pharmaceuticals International, plc | 50,490 | $2.0M | 10b5-1 | Oct 20, 2025 | Form 4 ↗ 2 days later · 50,490 shares | Form 144 ↗ |
| Oct 14, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 12,368 | $465.8K | 10b5-1 | Oct 14, 2025 | Form 4 ↗ 2 days later · 12,368 shares | Form 144 ↗ |
| Sep 29, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 42,000 | $1.6M | 10b5-1 | Sep 29, 2025 | Form 4 ↗ 2 days later · 42,000 shares | Form 144 ↗ |
| Sep 15, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 16,400 | $598.0K | 10b5-1 | Sep 15, 2025 | Form 4 ↗ 2 days later · 16,400 shares | Form 144 ↗ |
| Sep 5, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 13,389 | $477.5K | 10b5-1 | Sep 5, 2025 | Form 4 ↗ 3 days later · 98,660 shares | Form 144 ↗ |
| Sep 4, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 85,271 | $3.0M | 10b5-1 | Sep 4, 2025 | Form 4 ↗ 4 days later · 98,660 shares | Form 144 ↗ |
| Sep 4, 2025 | Moat Ross Officer | KNSA Kiniksa Pharmaceuticals International, plc | 3,523 | $124.4K | 10b5-1 | Sep 4, 2025 | Form 4 ↗ 4 days later · 3,523 shares | Form 144 ↗ |
| Sep 3, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 15,091 | $535.8K | 10b5-1 | Sep 3, 2025 | Form 4 ↗ same day · 15,091 shares | Form 144 ↗ |
| Sep 3, 2025 | Michael R. Megna Officer | KNSA Kiniksa Pharmaceuticals International, plc | 11,000 | $383.2K | 10b5-1 | Sep 3, 2025 | Form 4 ↗ same day · 11,000 shares | Form 144 ↗ |
| Aug 18, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 16,200 | $547.1K | 10b5-1 | Aug 18, 2025 | Form 4 ↗ 2 days later · 16,200 shares | Form 144 ↗ |
| Aug 14, 2025 | Malley Thomas Director | KNSA Kiniksa Pharmaceuticals International, plc | 78,233 | $2.6M | — | Aug 14, 2025 | Form 4 ↗ same day · 177,769 shares | Form 144 ↗ |
| Aug 13, 2025 | Malley Thomas Director | KNSA Kiniksa Pharmaceuticals International, plc | 50,129 | $1.7M | — | Aug 13, 2025 | Form 4 ↗ 1 day later · 177,769 shares | Form 144 ↗ |
| Aug 12, 2025 | Malley Thomas Director | KNSA Kiniksa Pharmaceuticals International, plc | 49,407 | $1.6M | — | Aug 12, 2025 | Form 4 ↗ 2 days later · 177,769 shares | Form 144 ↗ |
| Aug 6, 2025 | John F. Paolini Officer | KNSA Kiniksa Pharmaceuticals International, plc | 29,325 | $954.5K | 10b5-1 | Aug 6, 2025 | Form 4 ↗ 2 days later · 29,325 shares | Form 144 ↗ |
| Aug 5, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 138,614 | $4.6M | 10b5-1 | Aug 5, 2025 | Form 4 ↗ 2 days later · 138,614 shares | Form 144 ↗ |
| Aug 4, 2025 | Mark Ragosa Officer | KNSA Kiniksa Pharmaceuticals International, plc | 18,889 | $621.3K | 10b5-1 | Aug 4, 2025 | Form 4 ↗ 2 days later · 18,889 shares | Form 144 ↗ |
| Aug 4, 2025 | Michael R. Megna Officer | KNSA Kiniksa Pharmaceuticals International, plc | 17,000 | $549.9K | 10b5-1 | Aug 4, 2025 | Form 4 ↗ 2 days later · 17,000 shares | Form 144 ↗ |
| Jul 30, 2025 | Kimberly J. Popovits Director | KNSA Kiniksa Pharmaceuticals International, plc | 64,508 | $1.9M | — | Jul 30, 2025 | — | Form 144 ↗ |
| Jul 14, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 18,900 | $542.9K | 10b5-1 | Jul 14, 2025 | Form 4 ↗ 2 days later · 18,900 shares | Form 144 ↗ |
| Jun 16, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 17,300 | $489.2K | 10b5-1 | Jun 16, 2025 | Form 4 ↗ 2 days later · 17,300 shares | Form 144 ↗ |
| Jun 11, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 45,042 | $1.4M | 10b5-1 | Jun 11, 2025 | Form 4 ↗ same day · 70,867 shares | Form 144 ↗ |
| Jun 10, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 15,506 | $472.2K | 10b5-1 | Jun 10, 2025 | Form 4 ↗ 1 day later · 70,867 shares | Form 144 ↗ |
| Jun 9, 2025 | Tessari Eben Officer | KNSA Kiniksa Pharmaceuticals International, plc | 10,319 | $313.5K | 10b5-1 | Jun 9, 2025 | Form 4 ↗ 2 days later · 70,867 shares | Form 144 ↗ |
| Jun 9, 2025 | Barry D. Quart Director | KNSA Kiniksa Pharmaceuticals International, plc | 27,448 | $830.6K | — | Jun 9, 2025 | Form 4 ↗ 2 days later · 27,448 shares | Form 144 ↗ |
| Jun 3, 2025 | Michael R. Megna Officer | KNSA Kiniksa Pharmaceuticals International, plc | 15,211 | $437.3K | 10b5-1 | Jun 3, 2025 | Form 4 ↗ 2 days later · 15,211 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:56 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances